Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Appoints Andrew Davis as Chief Commercial Officer

See Release

All News

Archives

Endologix Wins “Medical Device Engineering Breakthrough” Award in 7th Annual MedTech Breakthrough Awards Program

Five-Year Results of the LEOPARD Trial published in the Journal of Vascular Surgery (JVS)

Endologix Receives FDA Approval of PMA Supplement for AFX2 System

Endologix Announces 12-Month Results of DETOUR-2 Trial at 2022 VIVA Late-Breaking Clinical Trial Session

Endologix Reports Five-Year Data of the LEOPARD Trial at 2022 Vascular InterVentional Advances (VIVA) Conference